Interventionalist: More trials necessary to determine if renal denervation can work

04/21/2014 | Medscape (free registration)

Additional trials may be necessary to ascertain if renal denervation technology doesn't work or simply needs further optimization, said SCAI fellow Dr. Rajiv Gulati, who discusses the SYMPLICITY HTN-3 study results in this video. "One issue with this technology is that there is no readout for procedural success," he said. "Whether you are an experienced or a novice operator, you don't know for certain whether you have achieved denervation. If there were a technology that gave a readout, it would go a long way to answering the question about whether denervation works."

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC